Filters

João Mauricio Castaldelli-Maia, Arthur Guerra de Andrade, Cintia de Azevedo-Marques Périco, Antonio Ventriglio, Julio Torales, Marcela Waisman Campos, Dangela Layne Silva Lassi, Israel Kanaan Blaas, Guilherme Trevizan Kortas, Mayra Cruz Preto

International review of psychiatry (Abingdon, England) 2024;35(5-6):434-449

Full Text

Abstract

The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.

Debra S Karhson, Haley A Vecchiarelli, Cecilia J Hillard, Margaret Haney, Matthew N Hill

Psychological medicine 2023;53(15):7006-7024

Free Full Text

Abstract

The Neurotherapeutic Arsenal in : Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects.

Ahmad K Al-Khazaleh, Elaf Adel Al-Dalabeeh, Deep Jyoti Bhuyan, Dennis Chang, Kayla Jaye, Xian Zhou, Gerald W Münch

Molecules (Basel, Switzerland) 2024;29(2):

Free Full Text

Abstract

Results: 1 – 15 / 49

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cannabinoid Receptor Agonists""[mesh_terms]

Recent Research on L.: Phytochemistry, New Matrices, Cultivation Techniques, and Recent Updates on Its Brain-Related Effects (2018-2023).

Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.

The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential.

Role of Cannabinoids in Oral Cancer.

Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds.

An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products.

Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights.

An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects.

Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities.

The evolution of cannabinoid receptors in cancer.

Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.

CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.

Unravelling the landscape of craving pharmacological treatments: a PRISMA-guided review of evidence.

The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.

The Neurotherapeutic Arsenal in : Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects.

Results for
""Cannabinoid Receptor Agonists""[mesh_terms]